Anthem Blue Cross Blue Shield of Colorado policy
MED.00135 Gene Therapy for Hemophilia
MED.00135 Gene Therapy for Hemophilia is a public Anthem Blue Cross Blue Shield of Colorado policy (policy MED.00135). It lists 6 CPT or HCPCS codes, 3 of them on the Anthem Blue Cross Blue Shield of Colorado prior authorization list. Not a coverage decision; the payer's own document governs.
- Policy number
- MED.00135
- Line of business
- Commercial
- Source
- www.anthem.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Prior authorization status is from the Anthem Blue Cross Blue Shield of Colorado prior authorization list.
| Code | Prior authorization | Description on the prior authorization list | Other Anthem Blue Cross Blue Shield of Colorado policies |
|---|---|---|---|
| C9399 | Not listed | Policies naming C9399 | |
| J1411 | On the list | Injection, etranacogene dezaparvovec-drlb, per therapeutic dose | Policies naming J1411 |
| J1412 | On the list | Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes | Policies naming J1412 |
| J1414 | On the list | Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose | Policies naming J1414 |
| J3490 | Not listed | Policies naming J3490 | |
| J3590 | Not listed | Policies naming J3590 |
All Anthem Blue Cross Blue Shield of Colorado policies · Anthem Blue Cross Blue Shield of Colorado prior authorization CPT list